Correlation Between Cabio Biotech and Uxi Unicomp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cabio Biotech and Uxi Unicomp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cabio Biotech and Uxi Unicomp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cabio Biotech Wuhan and Uxi Unicomp Technology, you can compare the effects of market volatilities on Cabio Biotech and Uxi Unicomp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cabio Biotech with a short position of Uxi Unicomp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cabio Biotech and Uxi Unicomp.

Diversification Opportunities for Cabio Biotech and Uxi Unicomp

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cabio and Uxi is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cabio Biotech Wuhan and Uxi Unicomp Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uxi Unicomp Technology and Cabio Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cabio Biotech Wuhan are associated (or correlated) with Uxi Unicomp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uxi Unicomp Technology has no effect on the direction of Cabio Biotech i.e., Cabio Biotech and Uxi Unicomp go up and down completely randomly.

Pair Corralation between Cabio Biotech and Uxi Unicomp

Assuming the 90 days trading horizon Cabio Biotech Wuhan is expected to under-perform the Uxi Unicomp. In addition to that, Cabio Biotech is 1.31 times more volatile than Uxi Unicomp Technology. It trades about -0.43 of its total potential returns per unit of risk. Uxi Unicomp Technology is currently generating about -0.33 per unit of volatility. If you would invest  5,232  in Uxi Unicomp Technology on October 16, 2024 and sell it today you would lose (636.00) from holding Uxi Unicomp Technology or give up 12.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cabio Biotech Wuhan  vs.  Uxi Unicomp Technology

 Performance 
       Timeline  
Cabio Biotech Wuhan 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cabio Biotech Wuhan are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cabio Biotech may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Uxi Unicomp Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Uxi Unicomp Technology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Uxi Unicomp is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cabio Biotech and Uxi Unicomp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cabio Biotech and Uxi Unicomp

The main advantage of trading using opposite Cabio Biotech and Uxi Unicomp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cabio Biotech position performs unexpectedly, Uxi Unicomp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uxi Unicomp will offset losses from the drop in Uxi Unicomp's long position.
The idea behind Cabio Biotech Wuhan and Uxi Unicomp Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum